Showing results (111-120 of 158) with videos related to
Sort By:
Pageof 16
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 20, 2019
Unravelling the transcriptional responses of TGF-β: Smad3 and EZH2 constitute a regulatory switch that controls neuroretinal epithelial cell fate specificationDarrell Andrews, Giorgio Oliviero, Letizia De Chiara, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2024
The TNFSF12/TWEAK Modulates Colonic Inflammatory Fibroblast Differentiation and Promotes Fibroblast-Monocyte InteractionsCarlos Matellan, Ciarán Kennedy, Miren Itxaso Santiago-Vela, et al.BMJ Open Diabetes Research & Care|August 5, 2020
Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney diseaseMeera Nair, William P Martin, Vadim Zhernovkov, et al.Biochimica Et Biophysica Acta|April 10, 2013
IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responsesJames B Corcoran, Sarah McCarthy, Brenda Griffin, et al.The American Journal of Pathology|August 13, 2013
Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activityJason P McMorrow, Daniel Crean, Martina Gogarty, et al.Journal of the American Society of Nephrology : JASN|May 30, 2008
IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosisMadeline Murphy, Neil G Docherty, Brenda Griffin, et al.Frontiers in Endocrinology|February 28, 2022
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney DiseaseWilliam P Martin, Yeong H D Chuah, Mahmoud Abdelaal, et al.BMC Genomics|June 10, 2024
Genetic variants affecting mitochondrial function provide further insights for kidney diseaseMarisa Cañadas-Garre, Blanca Baños-Jaime, Joaquín J Maqueda, et al.Pharmacological Research|January 25, 2021
Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammationIzabela Galvão, Eliza M Melo, Vivian L S de Oliveira, et al.Epigenetics|May 12, 2010
DNA methylation profiling in cell models of diabetic nephropathyEoin P Brennan, Mathias Ehrich, Helen O'Donovan, et al.Pageof 16